Please read Full Inclusion and Exclusion Criteria below carefully.
Study Hours: 8:30 a.m. to 5:30 p.m.
Visit 1: Baseline – Thursday, 12/8 – 20 minutes
Visit 2: Final – Thursday, 12/22 – 20 minutes
a. Subject is male or female between 18-65 years of age;
b. Subject has self perceived non-sensitive skin;
c. Subjects are free of any systemic or dermatological disorders including any known history of allergies or other medical conditions which, in the opinion of the medical investigator(s), could interfere with the conduct of the study, interpretation of results or increase the risk of adverse reactions;
d. Subjects are willing to complete the course of the study and comply with Instructions;
e. Subjects are able to read, understand and provide written informed consent in conformance with 21 CFR part 50, “Protection of Human Subjects”;
f. Subjects are willing to complete a HIPAA authorization form in conformance with 45 CFR Parts 160 and 164;
g. Subjects must agree to refrain from using current body exfoliators, scrubs, or polish, etc.
h. Subjects must be regular users of cosmetics and/or toiletries;
i. Subjects must agree not to use any new personal care products during the course of the study;
a. Female subject is pregnant, nursing, planning a pregnancy, or not using adequate birth control;
b. Subjects with any skin conditions that, in the opinion of the medical investigator(s) (Board Certified Dermatologist), could interfere with the conduct of the study or increase the risks to the test subject (e.g. excessive redness or dryness, abnormal pigmentation);
c. Subjects with known allergies to any shower and/or bath products (shower gel, body wash, body scrub, etc.);
d. Subjects are taking or planning to take medications which could interfere with the test results, including any regimen of steroidal/non-steroidal anti-inflammatory drugs or antihistamines, during the course of the study;
e. Subjects who are currently under treatment for asthma or diabetes (insulin dependent);
f. Subjects with a history of cancer;
g. Subjects who are currently participating in a clinical research study or who have participated in a clinical study involving the arms, legs or torso within the last seven (7) days;
h. Subjects with psoriasis, active atopic dermatitis, eczema, or sunburn at the test sites;
i. Subjects with excessive dryness or redness at the test sites;
j. Subjects with tattoos or piercings at the test sites;
k. Subjects who are staff members of the lab.